May Arthritis News Roundup

The Arthritis Foundation is your trusted source for information, and we’re staying on top of the latest arthritis-related news that could affect you. Here’s what you need to know about some of the headlines from this past month.

Coronavirus and Arthritis News
The new coronavirus pandemic has created a new normal for us to live in and has changed the way you are able to manage your arthritis. We’re keeping you updated on the latest developments, and talking to top experts to get credible, reliable information you need to know about COVID-19 and how it may impact you and your arthritis. Find the latest on our Care & Connect resource center.

New Inflammatory Illness Emerging in Children
The COVID-19 pandemic is causing high levels of anxiety and stress around the globe, especially for those who are at higher risk for severe illness from the new coronavirus. Although reports show children are much less likely than adults to contract it, a number of children have become ill with a new inflammatory illness similar to Kawasaki disease, a rheumatic disease that typically occurs in infants and young children. Despite similarities, it appears this emerging syndrome is a unique disease, which can be severe and sometimes fatal.

The Centers for Disease Control and Prevention calls it multisystem inflammatory syndrome in children (MIS-C), and rheumatologists – experts in inflammatory conditions – are on the front lines in efforts to understand and treat it. The Arthritis Foundation is following developments with MIS-C. Read more about this emerging inflammatory illness.

Study Finds No Evidence to Support Hydroxycholoroquine Use for COVID-19
A new study has been released by the New England Journal of Medicine showing no supporting evidence for treating patients affected by the coronavirus with the drug hydroxychloroquine. The doctors involved in the study examined the association between hydroxychloroquine use and respiratory failure at a large medical center providing care to a substantial number of coronavirus patients in New York City.

The specific results they discovered from observing patients can be read in detail, along with how they came to their conclusion about hydroxychloroquine.

New Study Finds Inflammation, Thrombosis May Predict Critical COVID-19 Cases
Although there are still so many things we don’t know about COVID-19, new information continues to emerge every day. One thing experts agree on for people with arthritis is that it’s more important now than ever to keep disease activity and inflammation levels low. A new study released from case data in New York shows biomarkers for inflammation and thrombosis may predict the critical and fatal COVID-19 case outcomes. Read more about this study.

Learn ways to maintain your arthritis care during the COVID-19 pandemic.

In Other Arthritis News

The Right Supplements for Treating OA
Treatments for osteoarthritis (OA), a disabling and incurable condition, aim to provide relief for joint pain and inflammation. Recent evidence has challenged the traditional recommendations of paracetamol and NSAIDs. Increasingly patients, particularly those with greater knowledge of their condition and better self-rated health status, turn to the use of supplements and alternative medicines due to their easy accessibility.

It’s important to know which supplements are effective against arthritis pain, and which are a waste of time of money, in order to effectively treat OA symptoms and their effects.

New Gout Treatment Guidelines Released
Just in time for Gout Awareness Day on May 22, the American College of Rheumatology has released new guidelines for treating and managing this inflammatory form of arthritis. Characterized by sudden, severe pain in one or more joints — often the big toe — gout affects more than 9 million adults in the U.S. Read some highlights from the guidelines and talk to your doctor to see if these new recommendations could help ease your gout pain.

Topical NSAID Now Available Over-The-Counter
The FDA recently approved Voltaren Topical Arthritis Pain Relief Gel to be available over-the-counter through the FDA’s “Rx-to-OTC” switch process. Medications involved in this process must be shown to be safe to use without physician supervision. Over-the-counter medicines (OTC) are easier to access since they don’t require a prescription, so this is a big win for those suffering from arthritis pain.

Find out more information about Voltaren Arthritis Pain and check your local drugstore to try this easy-to-use gel for topical pain relief.

NOTE: For every donation made to Arthritis Foundation before May 31, Voltaren will match up to $100,000.

 

Leave a Reply

Your email address will not be published. Required fields are marked *